Progyny, Inc.
10
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Eeva™ Pregnancy Investigational Clinical Study: A Postmarket Follow-Up Study
Role: lead
Eeva™ Pregnancy Pilot Study (PPS)
Role: lead
US Eeva™ Pregnancy Investigational Clinical Study (US EPIC)
Role: lead
Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)
Role: lead
Eeva System Imaging Study
Role: lead
Registry Study of Traditional Morphology Grading Combined With Eeva in IVF Treatment
Role: lead
Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results
Role: lead
Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting
Role: lead
Eeva 12-well Dish Study
Role: lead
Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst Stage
Role: lead
All 10 trials loaded